nodes	percent_of_prediction	percent_of_DWPC	metapath
Lucanthone—TOP2A—Epirubicin—bone cancer	0.488	0.653	CbGbCtD
Lucanthone—TOP2A—Doxorubicin—bone cancer	0.26	0.347	CbGbCtD
Lucanthone—APEX1—HIF-2-alpha transcription factor network—CITED2—bone cancer	0.024	0.0991	CbGpPWpGaD
Lucanthone—APEX1—Gap-filling DNA repair synthesis and ligation in GG-NER—RFC1—bone cancer	0.0157	0.0649	CbGpPWpGaD
Lucanthone—APEX1—Lagging Strand Synthesis—RFC1—bone cancer	0.0133	0.0548	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.0126	0.052	CbGpPWpGaD
Lucanthone—APEX1—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.0123	0.051	CbGpPWpGaD
Lucanthone—APEX1—Extension of Telomeres—RFC1—bone cancer	0.0103	0.0424	CbGpPWpGaD
Lucanthone—APEX1—DNA strand elongation—RFC1—bone cancer	0.00948	0.0391	CbGpPWpGaD
Lucanthone—APEX1—Global Genomic NER (GG-NER)—RFC1—bone cancer	0.00903	0.0373	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00728	0.0301	CbGpPWpGaD
Lucanthone—APEX1—Transcription-coupled NER (TC-NER)—RFC1—bone cancer	0.00722	0.0298	CbGpPWpGaD
Lucanthone—APEX1—Homologous Recombination Repair—BRCA2—bone cancer	0.0069	0.0285	CbGpPWpGaD
Lucanthone—APEX1—Nucleotide Excision Repair—RFC1—bone cancer	0.00663	0.0274	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00552	0.0228	CbGpPWpGaD
Lucanthone—APEX1—Double-Strand Break Repair—BRCA2—bone cancer	0.00542	0.0224	CbGpPWpGaD
Lucanthone—APEX1—Telomere Maintenance—RFC1—bone cancer	0.00465	0.0192	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RFC1—bone cancer	0.00394	0.0163	CbGpPWpGaD
Lucanthone—APEX1—Chromosome Maintenance—RFC1—bone cancer	0.00387	0.016	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RFC1—bone cancer	0.00369	0.0152	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—RFC1—bone cancer	0.00346	0.0143	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RFC1—bone cancer	0.00323	0.0133	CbGpPWpGaD
Lucanthone—APEX1—Doxorubicin—Epirubicin—bone cancer	0.00319	0.35	CbGdCrCtD
Lucanthone—APEX1—Epirubicin—Doxorubicin—bone cancer	0.00295	0.324	CbGdCrCtD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.0025	0.0103	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—IGF1R—bone cancer	0.00225	0.00927	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00213	0.00879	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00194	0.00801	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—GNA11—bone cancer	0.00187	0.00772	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—EZH2—bone cancer	0.00186	0.00769	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00177	0.00729	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00174	0.00719	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—CDK4—bone cancer	0.00173	0.00714	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.00173	0.00712	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—ZW10—bone cancer	0.0016	0.00661	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—BRAF—bone cancer	0.00153	0.00632	CbGpPWpGaD
Lucanthone—APEX1—DNA Repair—BRCA2—bone cancer	0.00152	0.00626	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—RB1—bone cancer	0.0015	0.00621	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00148	0.00609	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—ZW10—bone cancer	0.00143	0.00591	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.00142	0.00584	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00122	0.00504	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.00121	0.00501	CbGpPWpGaD
Lucanthone—APEX1—TSH signaling pathway—JUN—bone cancer	0.00111	0.0046	CbGpPWpGaD
Lucanthone—APEX1—Synthesis of DNA—RB1—bone cancer	0.00111	0.0046	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RFC1—bone cancer	0.0011	0.00454	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00109	0.00452	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—CDK4—bone cancer	0.00109	0.00449	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TUBB4B—bone cancer	0.00108	0.00448	CbGpPWpGaD
Lucanthone—APEX1—S Phase—CDK4—bone cancer	0.00105	0.00434	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—CDK4—bone cancer	0.00105	0.00434	CbGpPWpGaD
Lucanthone—APEX1—DNA Replication—RB1—bone cancer	0.00105	0.00432	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RFC1—bone cancer	0.000983	0.00406	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—RB1—bone cancer	0.000945	0.0039	CbGpPWpGaD
Lucanthone—APEX1—S Phase—RB1—bone cancer	0.000914	0.00377	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000859	0.00355	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000812	0.00335	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000782	0.00323	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000782	0.00323	CbGpPWpGaD
Lucanthone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000778	0.00321	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—PTGS2—bone cancer	0.000777	0.00321	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000742	0.00306	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.00074	0.00305	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000705	0.00291	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—MMP9—bone cancer	0.000681	0.00281	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—DHFR—bone cancer	0.000681	0.00281	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—JUN—bone cancer	0.000677	0.0028	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000665	0.00275	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—ZW10—bone cancer	0.000662	0.00273	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000641	0.00265	CbGpPWpGaD
Lucanthone—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000623	0.00257	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—DHFR—bone cancer	0.000609	0.00252	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000606	0.0025	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000584	0.00241	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000581	0.0024	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000561	0.00232	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000558	0.0023	CbGpPWpGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000555	0.00229	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000552	0.00228	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—EGFR—bone cancer	0.000551	0.00227	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000544	0.00225	CbGpPWpGaD
Lucanthone—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.000515	0.0565	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Epirubicin—bone cancer	0.000515	0.0565	CbGdCrCtD
Lucanthone—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.000515	0.0565	CbGdCrCtD
Lucanthone—APEX1—Cell Cycle—CHEK2—bone cancer	0.000509	0.0021	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000508	0.0021	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000501	0.00207	CbGpPWpGaD
Lucanthone—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.000477	0.0523	CbGdCrCtD
Lucanthone—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.000477	0.0523	CbGdCrCtD
Lucanthone—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.000477	0.0523	CbGdCrCtD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.000476	0.00196	CbGpPWpGaD
Lucanthone—Amiodarone—CYP3A4—bone cancer	0.000471	0.678	CrCbGaD
Lucanthone—TOP1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000466	0.00192	CbGpPWpGaD
Lucanthone—APEX1—Spinal Cord Injury—TP53—bone cancer	0.000462	0.00191	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000461	0.0019	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RFC1—bone cancer	0.000455	0.00188	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000451	0.00186	CbGpPWpGaD
Lucanthone—TOP1—Circadian rythm related genes—TP53—bone cancer	0.000447	0.00185	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—BRCA2—bone cancer	0.000432	0.00178	CbGpPWpGaD
Lucanthone—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000392	0.00162	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—CDK4—bone cancer	0.000358	0.00148	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000342	0.00141	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000328	0.00136	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—CDK4—bone cancer	0.00032	0.00132	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000315	0.0013	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle, Mitotic—RB1—bone cancer	0.000311	0.00129	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—DHFR—bone cancer	0.000282	0.00116	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—RB1—bone cancer	0.000278	0.00115	CbGpPWpGaD
Lucanthone—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000273	0.00113	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000254	0.00105	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000244	0.00101	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—MDM2—bone cancer	0.000237	0.00098	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000236	0.000972	CbGpPWpGaD
Lucanthone—Flurazepam—CYP3A4—bone cancer	0.000223	0.321	CrCbGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.00022	0.00091	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000212	0.000873	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—BRCA2—bone cancer	0.0002	0.000824	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000173	0.000715	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	0.000166	0.000684	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—CDK4—bone cancer	0.000148	0.000611	CbGpPWpGaD
Lucanthone—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000145	0.000601	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	0.000144	0.000594	CbGpPWpGaD
Lucanthone—TOP2A—Circadian rythm related genes—TP53—bone cancer	0.00014	0.000577	CbGpPWpGaD
Lucanthone—APEX1—Cell Cycle—TP53—bone cancer	0.000136	0.000562	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—RB1—bone cancer	0.000129	0.000531	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—MDM2—bone cancer	0.00011	0.000453	CbGpPWpGaD
Lucanthone—TOP2A—Cell Cycle—TP53—bone cancer	6.3e-05	0.00026	CbGpPWpGaD
